Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
US7622451B2 · kind B2 · utility
105Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2007 |
| Grant date | Nov 24, 2009 |
| Priority date | — |
| Expiry date | Apr 25, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novobiocin analogues and pharmaceutical composition containing such compounds useful for the treatment and/or prevention of neurodegenerative disorders and autoimmune disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.